NS Wind Down Co (NSTGQ) Stock Price
NS Wind Down Co Price
Over the last 14 years NS Wind Down Co grew revenue by 36.7% annually, reaching 127.26 M USD. For NS Wind Down Co, the net margin of -125.4% is down versus -72.5% a few years ago.
NS Wind Down Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
NS Wind Down Co business model & stock analysis
Frequently asked questions about NS Wind Down Co
NanoString Technologies Inc. is a leading provider of life science tools for translational research and molecular diagnostics. The business model of NanoString Technologies is focused on developing and commercializing proprietary technologies, including the nCounter Analysis System, which enables researchers to profile gene expression and gain insights into a wide range of biological systems and diseases. By offering high-quality, scalable, and easy-to-use solutions, NanoString Technologies aims to empower researchers in various fields, including drug development, biomarker discovery, and cancer research. With a strong emphasis on innovation and customer satisfaction, NanoString Technologies Inc. strives to deliver cutting-edge solutions that drive advancements in molecular biology and enable breakthrough discoveries.
NanoString Technologies Inc is primarily active in the field of life sciences and healthcare industries.
The main competitors of NanoString Technologies Inc in the market are Illumina Inc, Thermo Fisher Scientific Inc, and QIAGEN N.V.
NanoString Technologies Inc. is a leading provider of life science tools for translational research and molecular diagnostics. Founded in 2003, the company is headquartered in Seattle, Washington. NanoString's innovative nCounter Analysis System enables researchers to perform high-resolution analysis of gene expression and DNA/RNA analysis, offering a powerful platform for understanding disease pathways, drug responses, and biomarker discovery. With a focus on precision oncology and immunology, NanoString Technologies Inc. has established collaborations with various academic institutions and pharmaceutical companies. The company has consistently expanded its product portfolio and continues to play a significant role in advancing molecular research and personalized medicine. NanoString Technologies Inc. is committed to revolutionizing the field of genomics through its cutting-edge technology and collaborations.
NanoString Technologies Inc has achieved several significant milestones. Firstly, the company developed and commercialized the nCounter Analysis System, a unique platform for molecular profiling. This innovative technology has empowered researchers to explore biological systems with high precision. Additionally, NanoString Technologies Inc launched various genomic panels, including the Prosigna Breast Cancer Assay, which enables healthcare professionals to make informed decisions regarding breast cancer management. The company has also forged strategic partnerships with leading institutions and pharmaceutical companies to advance precision medicine. NanoString Technologies Inc continues to make strides in the field of molecular diagnostics and remains dedicated to driving advancements in personalized medicine.
NanoString Technologies Inc is primarily present in various countries and regions worldwide. The company has a global presence, with notable operations in the United States, Europe, Asia-Pacific, and Latin America. NanoString Technologies Inc has established a strong network of customers, collaborators, and distributors across these regions, enabling it to cater to a broad customer base. By continuously expanding its reach and forging strategic partnerships, NanoString Technologies Inc aims to deliver its innovative solutions for genetic analysis and provide value to researchers, clinicians, and diagnostic laboratories in different parts of the world.
NanoString Technologies Inc represents a commitment to innovation and advancement in the field of genomics. The company aims to provide solutions that enable researchers to deeply understand the intricacies of biology, thereby helping clinicians make more informed treatment decisions. NanoString believes in empowering its customers with cutting-edge technology, such as its nCounter Analysis System, which enables highly multiplexed, digital gene expression analysis. The company's corporate philosophy revolves around collaboration, integrity, and a passion for making a lasting impact on patient care and outcomes. NanoString Technologies Inc understands the significance of genomics in transforming healthcare and is dedicated to driving advancements in this rapidly evolving field.
15 analysts currently rate the NS Wind Down Co stock: 10 recommend buying, 5 holding and 0 selling.
Converted at the current exchange rate, the NS Wind Down Co share trades at 0.06 EUR (0.07 USD).
The NS Wind Down Co share (NSTGQ) is listed on 5 stock exchanges, including: NASDAQ (NSTG), SIX (Zürich) (0F1.SW), Frankfurt (0F1.F), München (0F1.MU), Düsseldorf (0F1.DU).
NanoString Technologies Inc is a biotechnology company focused on developing innovative products for genomics. The company's business model is based on manufacturing and selling devices, consumables, and services for genomic research. They offer the nCounter system for RNA and DNA analysis, specialized panels for specific applications, and diagnostic services. NanoString also has partnerships with other biotechnology companies to expand its product offerings. The company has a global presence with offices in North America, Europe, and Asia. NanoString's focus on research and development allows them to provide tailored solutions for customers and strive towards wider applications in diagnostics and precision medicine. Overall, NanoString is a leading player in genomics and is expected to continue diversifying and expanding its product portfolio to meet customer demands.
The revenue cannot currently be calculated for NS Wind Down Co.
The profit cannot currently be calculated for NS Wind Down Co.
The P/E ratio cannot be calculated for NS Wind Down Co at the moment.
The P/S cannot be calculated for NS Wind Down Co currently.
The Eulerpool Quality Score for NS Wind Down Co is 3/10.
The ISIN of NS Wind Down Co is US63009R1095. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of NS Wind Down Co is A1W1X2. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of NS Wind Down Co is NSTGQ. The ticker symbol is used to trade NS Wind Down Co shares on the stock exchange.
NS Wind Down Co stock
NS Wind Down Co Peer Group
NS Wind Down Co Ticker
NS Wind Down Co FIGI
All fundamentals and in-depth analysis of NS Wind Down Co
Our stock analysis for NS Wind Down Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NS Wind Down Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.